Kevin Eastwood

Kevin Eastwood is an accomplished executive with extensive experience in corporate development and business leadership within the biotechnology and pharmaceutical sectors. Currently serving as Chief Business Officer at Arpeggio Biosciences since May 2024, Eastwood has previously held significant roles including Executive Vice President of Corporate Development at Plexium and Vice President of Corporate Development at the California Institute for Biomedical Research. Notably, Eastwood co-founded and held leadership positions at multiple organizations, including eFFECTOR Therapeutics and Achillion Pharmaceuticals, and has held senior roles at Gilead Sciences and The Scripps Research Institute. Eastwood's academic background includes a Bachelor of Science in Biology and Chemistry from Missouri State University, obtained from 1982 to 1986.